The endosomal entry of EBOV is by GP1, while the low pH membrane fusion is coordinated by GP2 using Neimann-Pick C1 protein (NPC1), and thus implicated as major pathogenic determinants for infection [101] and the main target for the development of a vaccine for Ebola virus [105]. Here, NPC1 is linked to infection.